Track topics on Twitter Track topics that are important to you
The objective of this study is to determine if observations the investigators made in an animal model of sepsis can be translated to clinical practice. Specifically, the investigators will use the noninvasive Orthogonal Polarization Spectral (OPS) microscope and venous oxygen saturation to test the hypothesis that recombinant human erythropoietin(rHuEPO) will acutely improve the microcircualtion in septic patients in the ICU.
Sepsis is a systemic inflammatory response to a bacterial infection and is a common complication during the course of treatment of patients with multiple trauma and major surgery. In severe sepsis, the inflammatory response leads to multiple organ failure that can result in death. Multiple organ dysfunction in sepsis is now considered the most common cause of death in non-coronary critical care units. In fact, sepsis is one of the top 10 or 12 causes of death in the general population. Approximately 150,000 people die annually.1 On a microscopic level there is impairment in the relationship between oxygen delivery (DO2) and consumption (VO2) suggestive of defects in microcirculatory perfusion during septic shock.2,3,4 These alterations include a decrease in the proportion of perfused vessels smaller than 20 μm, which mostly are capillaries whereas flow in the larger perfusion vessels is preserved. As the micro-circulation alteration persists then multiple organ failure and death ensues,4 thus interventions able to improve the microcirculation may reduce tissue dysoxia. De Backer et. al.3 reported that topical application of acetylcholine can restore a normal microcirculatory flow pattern in patients with septic shock, indicating an important role for the micro-vascular endothelium, and that these alterations can be manipulated. Other experimental studies of several vasodilatory compounds have been shown to improve micro-vascular perfusion5,6,7,8,9 and even be associated with improved outcomes.7,10 In a human study, Spronk et. al.11 observed that intravenous administration of nitroglycerin resulted in a marked improvement in capillary perfusion, but this intervention may produce severe arterial hypotension and also increase some nitric oxide mediated cytoxic effects.12,13 In another human study, De Baker et. al.14 demonstrated that the administration of 5 μg/kg-min dobutamine can improve but not restore capillary perfusion in patients with septic shock and that these changes are independent of changes in systemic hemodynamic variables. The concomitant decrease in blood lactate level suggested the changes in the micro-vascular perfusion were associated with improved cellular metabolism. However, dobutamine may also produce hypotension in patients with hypovolemia.
Erythropoietin (EPO), a sialoglycoprotein hormone produced by the adult kidney, is a major regulator of red blood cell production but more recently has been suggested to have favourable effects on tissue injury and vascular function. It stimulates the proliferation of committed erythroid progenitor cells and their development into mature erythrocytes.15 Thus, the potential benefit of erythropoietin therapy in patients with anemia secondary to chronic renal failure has long been recognized.16 Recombinant Human EPO (rh-EPO) is indicated for the treatment of anemia associated with chronic renal failure, non-myeloid malignancies due to the effect of concomitantly administered chemotherapy, zidovudine treated HIV infected patients and patients under going major elective surgery to facilitate autologous blood collection thus to reduce allogenic blood exposure.
In critically ill adults and specifically those with sepsis, EPO levels have been shown to be relatively low with respect to the level of anemia present.17,18 As well, correlations were found between erythropoietin concentration and biological markers of tissue hypoperfusion i.e. lactate level or PCO2 gap.19 A common adverse effect of rh-EPO therapy in renal patients is the development of hypertension. The acute effects of rh-EPO on arterial vasoactivity suggest direct and indirect actions that occur prior to any effect on erythropoeisis. In addition to its hematopoietic effect, rh-EPO also has significant cardiovascular effects,20,21 including a direct vasopressor effect.22 In a rat splanchnic artery occlusion shock model, treatment with rh-EPO inhibited inducible nitric oxide synthase (iNOS) activity and prevented the overproduction of NO in vivo restoring responsiveness to Phenylephrine.23,24 Rh-EPO has direct vasopressor effects on smooth muscle cells, which express EPO receptors, modulating intracellular Ca++.25 An increase in the plasma levels of the endothelium derived vasoconstrictor endothelin-1 can occur after rh-EPO treatment.26,27,28 Indirect effects of EPO treatment may also increase the activity of the autonomic nervous system and increase sensitivity to angiotensin II, which is a potent vasoconstrictor.29 We recently reported that rh-EPO in a septic mouse model produces an immediate increase in the perfused capillary density with a concomitant decrease in NADH fluorescence, an indirect measure indicating improvement in mitochondical oxidative phosphorylation, in skeletal muscle. Thus, rh-EPO appears to improve tissue bioenergetics in this septic mouse model in part by maintaining DO2 via increased perfused capillary density.30 The recently developed, noninvasive orthogonal polarization spectral (OPS) imaging technique can be applied to investigate the human vasculature.34 Polarized light of defined wavelength (548 nm) is emitted to illuminate the area of interest, is reflected by the background but absorbed by hemoglobin, producing high-contrast images of the micro-circulation. This technique is particularly convenient for studying tissues protected by a thin epithelial layer, such as the mucosal surface35 and has been validated as an effective method of micro-vascular imaging in animals34, 36,37 and in humans.38 The OPS technique has been used to observe major micro-vascular blood flow alterations in patients with severe sepsis3 including a decreased vascular density, especially of the small vessels; a large number of non-perfused and intermittently perfused small vessels; and a marked perfusion heterogeneity between areas.39 These alterations were more severe in non-survivors than in survivors but were not affected by the global hemodynamic state or vasopressor agents.39 The persistence of micro-vascular alterations in patients with poor outcomes further emphasize the potential role of micro-circulatory disturbances in the pathophysiology of sepsis-induced multiple organ failure. In this study, we will use the OPS imaging technique to investigate the sublingual microcirculation in patients with septic shock after treatment with a single dose of rh-EPO. We hypothesize that rh-EPO will improve the sepsis-related alterations in micro-circulatory perfusion, independent of any systemic hemodynamic effects.
Time Perspective: Prospective
London Health Sciences Center-Critical Care Trauma Center
London Health Sciences Centre
Published on BioPortfolio: 2014-07-23T21:09:49-0400
To evaluate the discriminative power of BIS monitoring to classify the degree of mental state associated with the PCT graded sepsis cascade, and to assess its utility for monitoring the im...
In this prospective study, the ability of a machine learning algorithm to predict sepsis and influence clinical outcomes, will be investigated at Cabell Huntington Hospital (CHH).
A sepsis early warning predictive algorithm, InSight, has been developed and validated on a large, diverse patient cohort. In this prospective study, the ability of InSight to predict seve...
Breath samples will be collected from patients suspected of sepsis/severe sepsis or septic shock according to hospital sepsis screening criteria in the Emergency Department.
This study is designed for septic patients, to isolate MDSCs and the correlation of prognosis of sepsis. The purpose of this study hopes to explore the phenomenon and possible mechanisms o...
The new Sepsis-3 definitions have been scarcely assessed in low- and middle-income countries; besides, regional information of sepsis outcomes is sparse. Our objective was to evaluate Sepsis-3 definit...
Early-onset sepsis (EOS) is a potentially fatal condition that affects about 0.3-0.8/1,000 infants born at ≥35 weeks' gestation in developed countries. Current EOS management algorithms result in 8-...
Worldwide, both acute kidney injury (AKI) and sepsis are significant clinical complications, particularly in critical care patients. Sepsis is an important cause of AKI, and AKI is a common complicati...
Sepsis is among the leading causes of morbidity, mortality, and cost overruns in critically ill patients. Early intervention with antibiotics improves survival in septic patients. However, no clinical...
Cardiac arrest is not a common complication of sepsis, although sepsis has been recognized as one condition behind cardiac arrest. Our aim was to evaluate the prevalence of sepsis among patients with ...
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Acute neurological dysfunction during severe SEPSIS in the absence of direct brain infection characterized by systemic inflammation and BLOOD BRAIN BARRIER perturbation.
Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.
Test to determine the presence of blood infection (e.g. SEPSIS; BACTEREMIA).
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include, but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
Sepsis, septicaemia and blood poisoning
Septicaemia (another name for blood poisoning) refers to a bacterial infection of the blood, whereas sepsis can also be caused by viral or fungal infections. Sepsis is not just limited to the blood and can affect the whole body, including the organ...